PK/PD Studies
All our models are carefully optimized using key clinical comparators (positive controls) to establish a robust dynamic range. This allows us to explore PK/PD relationships and determine how drug exposure translates into meaningful effects on key model outcomes, such as reduced nociception in pain models.
We offer PK/PD studies across a wide range of preclinical species, including mice, rats, cats and dogs, tailored to your program needs. Our capabilities cover an extensive range of dosing routes, along with a broad range of behavioral endpoints and tissue/fluid collection services.
Applicable Portfolio Services
Have a program in mind?
Speak with our team to discuss your research goals and discover how Transpharmation's expertise in preclinical drug discovery can help accelerate your path to success. Contact us today to start the conversation.